These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 26971426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Value of Contrast-Enhanced Ultrasound in Diagnosing Small Renal Cell Carcinoma Subtypes and Angiomyolipoma.
    Cao H, Fang L, Chen L, Zhan J, Diao X, Liu Y, Lu C, Zhang Z, Chen Y.
    J Ultrasound Med; 2022 Jun; 41(6):1415-1423. PubMed ID: 34499770
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiomyolipoma with minimal fat: differentiation from clear cell renal cell carcinoma and papillary renal cell carcinoma by texture analysis on CT images.
    Yan L, Liu Z, Wang G, Huang Y, Liu Y, Yu Y, Liang C.
    Acad Radiol; 2015 Sep; 22(9):1115-21. PubMed ID: 26031228
    [Abstract] [Full Text] [Related]

  • 6. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H, Young JR, Douek ML, Brown MS, Sayre J, Raman SS.
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The independent indicators for differentiating renal cell carcinoma from renal angiomyolipoma by contrast-enhanced ultrasound.
    Cao H, Fang L, Chen L, Zhan J, Diao X, Liu Y, Lu C, Zhang Z, Chen Y.
    BMC Med Imaging; 2020 Mar 30; 20(1):32. PubMed ID: 32228606
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subjective and objective heterogeneity scores for differentiating small renal masses using contrast-enhanced CT.
    Leng S, Takahashi N, Gomez Cardona D, Kitajima K, McCollough B, Li Z, Kawashima A, Leibovich BC, McCollough CH.
    Abdom Radiol (NY); 2017 May 30; 42(5):1485-1492. PubMed ID: 28025654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
    Lee HS, Hong H, Jung DC, Park S, Kim J.
    Med Phys; 2017 Jul 30; 44(7):3604-3614. PubMed ID: 28376281
    [Abstract] [Full Text] [Related]

  • 18. Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation.
    Thaiss WM, Bedke J, Kruck S, Spira D, Stenzl A, Nikolaou K, Horger M, Kaufmann S.
    World J Urol; 2019 Jul 30; 37(7):1339-1346. PubMed ID: 30324296
    [Abstract] [Full Text] [Related]

  • 19. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
    Liang RX, Wang H, Zhang HP, Ye Q, Zhang Y, Zheng MJ, Xue ES, Zhu YF.
    Urol Oncol; 2021 Dec 30; 39(12):837.e19-837.e28. PubMed ID: 34654644
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.